ExSight Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
RevOpsis TherapeuticsSep 2025
BiotechSpringfield, US
Ramanath Bhandari(Executive Officer)Jeff Olson(Director)
BoardRam Palanki(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.